Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease

Pittock, S. J.; R. L. McClelland; S. J. Achenboch; F. Konig; A. Bitsch; Brück, W.; Lassmann, H.; Parisi, J. E.; Scheithauer, B. W.; Rodriguez, M.; Weinshenker, B. G.; Lucchinetti, C. F.
December 2005
Journal of Neurology, Neurosurgery & Psychiatry;Dec2005, Vol. 76 Issue 12, p1693
Academic Journal
Background: A pathological classification has been developed of early active multiple sclerosis (MS) lesions that reveals four patterns of tissue injury: I-T cell/macrophage associated; II-antibody/complement associated; III-distal oligodendrogliopathy, and IV-oligodendrocyte degeneration in the periplaque white matter. Mechanisms of demyelination in early MS may differ among the subgroups. Previous studies on biopsied MS have lacked clinicopathological correlation and follow up. Critics argue that observations are not generalisable to prototypic MS. Objective: To describe the clinicopathological characteristics of the MS Lesion Project biopsy cohort. Methods: Clinical characteristics and disability of patients with pathologically confirmed inflammatory demyelinating disease (excluding ADEM) classified immunopathologically (n = 91) and patients from the Olmsted County MS prevalence cohort (n=218) were determined. Results: Most patients who underwent biopsy and had pathologically proved demyelinating disease ultimately developed definite (n = 70) or probable (n =12) MS (median follow up 4.4 years). Most had a relapsing remitting course and 73% were ambulatory (EDSS ⩽ 4) at last follow up. Nine patients remained classified as having an isolated demyelinating syndrome at last follow up. Patients with different immunopathological patterns had similar clinical characteristics. Although presenting symptoms and sex ratios differed, the clinical course in biopsy patients was similar to the prevalence cohort. Median EDSS was <4.0 in both cohorts when matched for disease duration, sex, and age. Conclusions: Most patients undergoing biopsy, who had pathologically confirmed demyelinating disease, were likely to develop MS and remain ambulatory after a median disease duration of 4.4 years. The immunopathological patterns lacked specific clinical correlations and were not related to the timing of the biopsy. These data suggest that pathogenic implications derived largely from MS biopsy studies may be extrapolated to the general MS population.


Related Articles

  • Tumefactive demyelinating lesions: Characteristics of individual lesions, individual patients, or a unique disease entity? Weinshenker, Brian G. // Multiple Sclerosis Journal;Nov2015, Vol. 21 Issue 13, p1746 

    Whether or not recurrent tumefactive demyelinating lesions are a unique form of CNS demyelinating disease or part of the continuum of multiple sclerosis is a question raised by the case report on which this commentary is based. Detailed review and immunopathologic study of biopsy material may...

  • CLINICALLY ISOLATED SYNDROME: WHY TO TREAT? Bainbridge, Jacquelyn // University of Tennessee Advanced Studies in Pharmacy;2010, Vol. 7 Issue 3, p63 

    Clinically isolated syndrome (CIS) is the first symptomatic neurologic episode consistent with multiple sclerosis (MS). Because the majority of individuals with CIS and demyelinating lesions go on to develop clinically definite MS (CDMS), early detection and treatment is recommended to delay...

  • Candidate autoantigens in multiple sclerosis. Schmidt, S. // Multiple Sclerosis (13524585);Jun99, Vol. 5 Issue 3, p147 

    Multiple sclerosis is an inflammatory demyelinating CNS disease of putatively autoimmune origin. Novel models of experimental autoimmune encephalomyelitis (EAE) have demonstrated that T cells specific for various myelin and even nonmyelin proteins are potentially encephalitogenic. The...

  • Infection and multiple sclerosis. O'Donovan, M. // Journal of Neurology, Neurosurgery & Psychiatry;May2003, Vol. 74 Issue 5, p693 

    Comments on a paper on the role of infectious agents in multiple sclerosis (MS). Experience of living with MS; Speculatory nature of the paper; Impact of the paper on the reputation of MS research.

  • NEURODEGENERATION: THE CLINICAL EVIDENCE. Miravalle, Augusto // University of Tennessee Advanced Studies in Pharmacy;2010, Vol. 7 Issue 3, p57 

    Multiple sclerosis (MS) is a chronic inflammatory degenerative neurologic disorder that is usually characterized by episodic periods of acute exacerbations, gradual progressive deterioration of neurologic function, or combinations of both. Early diagnosis and treatment is crucial to delay...

  • Correlation between Magnetic Resonance Imaging Findings and Pathological Observations in Tumefactive Multiple Sclerosis. Kobayasahi, M.; Ono, Y.; Shibata, N.; Kobayashi, M.; Shimizu, Y.; Ohta, K.; Iwata, M.; Uchiyama, S. // Neuroradiology Journal;Apr2009, Vol. 22 Issue 2, p155 

    Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system. Tumefactive MS (TMS) is a subtype of MS characterized by solitary or multiple mass lesions with open-ring enhancement on brain magnetic resonance imaging (MRI). Three TMS cases, diagnosed...

  • Tumefactive Multiple sclerosis. Jitawatanarat, Potjana; Tingpej, Bhatraphol; Deringer, Paul // British Journal of Medical Practitioners;Jun2011, Vol. 4 Issue 2, p26 

    The article presents a case study of a 44 year old man presented with a two-month history of progressive right upper extremity weakness, confusion and visual change. Repeat Magnetic Resonance Imaging (MRI) of the brain revealed worsening multiple ring-enhancing lesions with surrounding vasogenic...

  • Experimental Models of Relapsing-Remitting Multiple Sclerosis: Current Concepts and Perspective. Skundric, Dusanka S. // Current Neurovascular Research;Oct2005, Vol. 2 Issue 4, p349 

    Multiple sclerosis (MS) and its model experimental autoimmune encephalomyelitis (EAE) are debilitating paralytic diseases caused by inflammation, demyelination and axonal degeneration of the central nervous system (CNS). Whilst the autoimmune nature of MS is strongly suggested by evidence of...

  • Focal and diffuse cortical degenerative changes in a marmoset model of multiple sclerosis. Pomeroy, I. M.; Jordan, E. K.; Frank, J. A.; Matthews, P. M.; Esiri, M. M. // Multiple Sclerosis (13524585);May2010, Vol. 16 Issue 5, p537 

    Background: Degenerative features, such as neuronal, glial, synaptic and axonal loss, have been identified in neocortical and other grey matter structures in patients with multiple sclerosis, but mechanisms for neurodegeneration are unclear. Cortical demyelinating lesions are a potential cause...


Read the Article


Sign out of this library

Other Topics